Bank of America’s Upstream Bio Inc UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$436K Sell
48,460
-37,924
-44% -$682K ﹤0.01% 4971
2025
Q4
$2.35M Buy
86,384
+30,911
+56% +$769K ﹤0.01% 3946
2025
Q3
$1.04M Buy
55,473
+37,442
+208% +$582K ﹤0.01% 5302
2025
Q2
$198K Buy
18,031
+7,500
+71% +$69.3K ﹤0.01% 6191
2025
Q1
$64.5K Sell
10,531
-3,432
-25% -$32.8K ﹤0.01% 6667
2024
Q4
$230K Buy
+13,963
New +$312K ﹤0.01% 6047

Other funds holding UPB

Bank of America's UPB Position: Q1 2026 in Review

Bank of America reduced its Upstream Bio Inc (UPB) stake by 44% in Q1 2026, selling an estimated $682K and leaving 48,460 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #4971.

Bank of America first reported a position in UPB in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.35M in Q4 2025. 140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • Bank of America held 48,460 shares of Upstream Bio Inc worth $436K as of Q1 2026.
  • Bank of America sold 37,924 Upstream Bio Inc shares in Q1 2026, an estimated $682K.
  • Upstream Bio Inc made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4971 holding.
  • Bank of America first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 6 quarters since.
  • Bank of America's Upstream Bio Inc position peaked at $2.35M in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.